Home Search
cancer - search results
If you're not happy with the results, please do another search
£2.3 million awarded to York University for sickle cell anaemia research
The Bill & Melinda Gates foundation have awarded £2.3million to the University of York, in attempt to push research into sickle cell anaemia.
NHS backlog to be resolved by 2025 in “most optimistic scenario”
A Health Committee report finds that in the "most optimistic scenario" of increased treatment over the next three years, the NHS backlog could come down to pre-pandemic levels in 2025.
UK appoints Women’s Health Ambassador to tackle gender health gap
The government are appointing a Women’s Health Ambassador to demonstrate stronger support for women’s health, as well as focusing on ending violence against women.
Shark antibody-like proteins could neutralise COVID-19 viruses
Antibody-like proteins from the immune systems of sharks could help to prepare for future coronaviruses, according to new research.
What are the side effects of the Moderna booster vaccine?
Here, we explain side effects of the Moderna booster vaccine - while taking a look at the Omicron variant.
Eyes on Planned Care
In a previous article, Lisa Riley, Vice President of Strategic Product and Partnership Development for VitalHub UK, cited how digital healthcare is helping to transform the NHS through whole system integration in planned care, here Stuart Jeffery talks from a customer perspective.
Getting personal in brain tumour therapy: Matching therapies to patients
Sean E. Lawler PhD from Brown University Cancer Center, an experienced scientist in the brain tumour field
Next generation sequencing in tissues: Capture methods
Richie Kohman, Synthetic Biology Platform Lead, Wyss Institute at Harvard, tells us about capture techniques to extract RNA from tissues.
Nurdles: Tiny building blocks of consumer plastics & a growing environmental health threat
Pamela Lein, University of California, Davis, explains nurdles - tiny building blocks of consumer plastics & growing environmental threat
LDPath: A virtual histopathology department for every NHS trust
Sanj Lallie, Director of Operations at LDPath, charts a vision of a virtual histopathology department for every NHS trust
Transforming pathology using digital platforms and AI
Rapidly scaling health-tech player in the emerging Pathology Computer Aided Diagnostics sector Deciphex uses digital pathology and AI to accelerate pathology diagnosis by improving productivity and patient outcome.
AI for breast imaging
Lester Litchfield, Data & Science Manager at Volpara Health analyses how to build trust in the use of AI to improve and enhance breast imaging.
Driving digital transformation across the UK healthcare sector
Brian Murphy, CSO of UK digital health firm Cumulus Neuroscience, explores how AI tools could transform drug development in the difficult area of cognitive disorders.
A WHO perspective on mental health
Dr Florence Baingana, Regional Advisor, Mental Health and Substance Abuse at WHO African Region speaks about mental health and why it is so important today
Metformin: A possible new treatment for endometriosis
Dr Deborah Lee, Dr Fox Online Pharmacy, discusses a possible new treatment for endometriosis - the condition that impacts atleast 1.5 million women in the UK.
Impact of air pollution on children’s health
Sarah Woolnough, Chief Executive of Asthma UK and the British Lung Foundation, and Andy Ratcliffe, Executive Director of Programmes at Impact on Urban Health, discuss the devastating effect air pollution has on children’s health, and why poor air quality is an unacceptable example of inequality in action.
Biomedical research across the globe: Why now is the time to invest in Africa
Dr Glass, Director of the Fogarty International Center, and Director at the NIH, explores the relationship between NIH and the health research community
Contemporary immunology and its relationship to medicine
Peter Bretscher, Professor of Biochemistry, Microbiology & Immunology at the University of Saskatchewan, explores important immunological questions
NIH discover new potential therapy for eye diseases
A new study shows promise for future therapies for blinding eye diseases, uveitis and multiple sclerosis.
Australia’s medical innovation approach: Is it suitable for regenerative medicine?
Australia has committed to investing heavily in its medical future – but will it be ready for the regenerative medicine revolution? John Gardner from Monash University and Michael Morrison from the University of Oxford provide the answer.
